GRTS Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 113393 min ago

@ $2.18

Wydano: 14 vas. 2024 @ 21:06

Zwrot: -60.00%

Poprzedni sygnał: vas. 13 - 22:42

Poprzedni sygnał: Sprzedaż

Zwrot: 3.82 %

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 23:00):

Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases...

Stats
Dzisiejszy wolumen	1.93M
Średni wolumen	2.78M
Kapitalizacja rynkowa	92.57M
EPS	$0 ( 2024-03-14 )
Następna data zysków	( $-0.300 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.720
ATR14	$0.00400 (0.46%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-26	Webster Stephen W	Buy	103 600	Stock Option (Right to Buy)
2024-04-26	Webster Stephen W	Sell	0	Common Stock
2024-02-01	Hawryluk Matthew	Buy	35 000	Common Stock
2024-02-01	Hawryluk Matthew	Buy	180 000	Stock Option (Right to Buy)
2024-02-01	Jones Erin	Buy	40 000	Common Stock

INSIDER POWER
100.00
Last 97 transactions
Buy: 6 032 442 \| Sell: 138 571

Wolumen Korelacja

Długi: 0.17 (neutral)

Krótki: -0.44 (neutral)

Signal:(45.201) Neutral

Gritstone Oncology Inc Korelacja

10 Najbardziej pozytywne korelacje
ATHN	0.855
MIND	0.854
PTRA	0.84
ARIZ	0.831
ISSC	0.821

10 Najbardziej negatywne korelacje
CURI	-0.872
ALR	-0.862
SAL	-0.858
IDN	-0.855
IZEA	-0.854
LABP	-0.853
MESO	-0.852
AFINO	-0.85
PMBC	-0.848
EPSN	-0.844

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Gritstone Oncology Inc Korelacja - Waluta/Towar

0.09
( neutral )

0.25
( neutral )

0.00
( neutral )

-0.08
( neutral )

Gritstone Oncology Inc Finanse

Annual	2023
Przychody:	$1.33M
Zysk brutto:	$-6.26M (-470.32 %)
EPS:	$-1.200

FY	2023
Przychody:	$1.33M
Zysk brutto:	$-6.26M (-470.32 %)
EPS:	$-1.200

FY	2022
Przychody:	$9.27M
Zysk brutto:	$-6.42M (-69.28 %)
EPS:	$-1.240

FY	2021
Przychody:	$48.21M
Zysk brutto:	$48.21M (100.00 %)
EPS:	$-0.965

Financial Reports:

No articles found.

Gritstone Oncology Inc

Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder and microsatellite stable, and colorectal cancers. The company is also developing SLATE, an off-the-shelf immunotherapy candidate for the treatment of common solid tumors comprising metastatic non-small cell lung cancer, colorectal cancer, pancreatic cancer, and shared neoantigen-positive tumors. In addition, it develops CORAL, a SARS-CoV-2 vaccine platform designed to deliver spike and additional SARS-CoV-2 T cell epitopes for protection and broader immunity against SARS-CoV-2 variants; and a therapeutic vaccine candidate designed to treat and cure human immunodeficiency virus (HIV) infection. It has a strategic collaboration with bluebird bio, Inc.; collaboration agreement with Gilead Sciences, Inc.; and license agreement with Genevant Sciences GmbH. The company was formerly known as Gritstone Oncology, Inc. and changed its name to Gritstone bio, Inc. in May 2021. Gritstone bio, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.